Last reviewed · How we verify

NCT04944277

Assessing Effectiveness of ThoughtFullChat Application in Improving Mental Well-Being

Completed NA Last updated 11 April 2022
What this trial tests

NA trial testing ThoughtFullChat Application in Anxiety in 353 participants. Completed in 28 February 2022.

Timeline
15 June 2021
Primary endpoint
31 January 2022
28 February 2022

Quick facts

Lead sponsorIMU University, Malaysia
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment353
Start date15 June 2021
Primary completion31 January 2022
Estimated completion28 February 2022
Sites1 location across Malaysia

Drugs / interventions tested

Conditions studied

Sponsor

IMU University, Malaysia

Who can join

18 and older, any sex, with Anxiety or Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

* To determine the state of mental health among house officers, IMU corporate staff, IMU students and IMU faculty * To find out the effectiveness and user experience of text-based mental health coaching applications among house officers, IMU corporate staff, IMU students and IMU faculty IMU - International Medical University

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Efficacy of a Text-Based Mental Health Coaching App in Improving the Symptoms of Stress, Anxiety, and Depression: Randomized Controlled Trial.
    Lim YS, Quek JH, Ching XW, Lim DTR, et al · · 2023 · cited 4× · PMID 37738081 · DOI 10.2196/46458

Verify or expand the search:

Other recruiting trials for Anxiety

Currently open trials in the same condition.

Other IMU University, Malaysia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04944277.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing